學門類別
政大
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- Leadership Imperatives in an AI World
- Vodafone Idea Merger - Unpacking IS Integration Strategies
- Predicting the Future Impacts of AI: McLuhan’s Tetrad Framework
- Snapchat’s Dilemma: Growth or Financial Sustainability
- V21 Landmarks Pvt. Ltd: Scaling Newer Heights in Real Estate Entrepreneurship
- Did I Just Cross the Line and Harass a Colleague?
- Winsol: An Opportunity For Solar Expansion
- Porsche Drive (B): Vehicle Subscription Strategy
- Porsche Drive (A) and (B): Student Spreadsheet
- TNT Assignment: Financial Ratio Code Cracker
-
Innovation and Agility at Tencent's WeChat
This case analyses the evolution of Tencent, now (in early 2019) one of the top 10 listed companies in the world. The case focuses on WeChat, the social networking and lifestyle app created in 2010 and now (in 2019) with more than one billion users. It describes the emergence and growth of WeChat and how it came to dominate large parts of daily life in China; it also provides insight into how WeChat operates and the current strategic challenges facing WeChat. Unlike some case studies on Tencent and WeChat, this case is based on in-depth interviews with executives in the company and in particular Allen Zhang, the founder of WeChat. It therefore provides an in-depth understanding of how WeChat works internally, and it allows the instructor to draw out some general points about innovation in today's mobile-first digital economy. -
Bayer's Innovation Agenda: Igniting Innovation in a 100,000-Person Company
The case describes how Bayer, one of the oldest and largest life-science companies in the world, recognised that innovation driven solely by the traditional R&D process that characterised the sector would not be sufficient to remain competitive, given the major changes underway in pharma and crop science and the broader trends in digital disruption. This recognition came from the very top, CEO Marijn Dekkers, who took the decision in 2015 to instigate a major corporate restructuring: Bayer would focus on its core life-science businesses (pharmaceuticals, consumer health and crop science) and spin off its material science business as a completely separate company. Beginning in 2016 under Board member Kemal Malik, Bayer began to put an innovation strategy in place that deliberately sought a systemic approach, meaning company-wide, to make innovation the responsibility of all Bayer employees. The question then arose how to put this vision into effect. How could Bayer promote greater innovation throughout the company, given that it had more than 100,000 employees spread over 75 countries? What actual initiatives could be undertaken to make innovation more effective and impactful? The case details how Monika Lessl, who reported directly to Malik, put in place a cross-divisional and cross-functional team to identify the most important areas to tackle and how, by 2018, the innovation programme she oversaw had "real momentum", with more than 1,000 people having some sort of formal role in support of innovation, more than 5,000 involved in innovation training, and more than 35,000 connected through the company's innovation portal.